Author

Esther Toes-Zoutendijk

IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS
IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS

Esther Toes-Zoutendijk  et al.

THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL
THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL

THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL
THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL

Esther Toes-Zoutendijk  et al.

IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS
IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS

STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM
STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM

RISK OF INTERVAL COLORECTAL CANCER AFTER NEGATIVE FIT BY QUANTITATIVE FIT-RESULT IN THE DUTCH CRC SCREENING PROGRAM
RISK OF INTERVAL COLORECTAL CANCER AFTER NEGATIVE FIT BY QUANTITATIVE FIT-RESULT IN THE DUTCH CRC SCREENING PROGRAM

Esther Toes-Zoutendijk  et al.

STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM
STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM

Esther Toes-Zoutendijk  et al.

DIFFERENCES IN TREATMENT OF STAGE I CRCS: A POPULATION-BASED STUDY OF CRCS DETECTED WITHIN AND OUTSIDE SCREENING
DIFFERENCES IN TREATMENT OF STAGE I CRCS: A POPULATION-BASED STUDY OF CRCS DETECTED WITHIN AND OUTSIDE SCREENING

Esther Toes-Zoutendijk  et al.

RISK STRATIFICATION IN COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
RISK STRATIFICATION IN COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED

Esther Toes-Zoutendijk  et al.

COST-EFFECTIVENESS OF PERSONALIZED SCREENING FOR COLORECTAL CANCER BASED ON PRIOR HEMOGLOBIN LEVELS
COST-EFFECTIVENESS OF PERSONALIZED SCREENING FOR COLORECTAL CANCER BASED ON PRIOR HEMOGLOBIN LEVELS

Esther Toes-Zoutendijk  et al.

NATIONWIDE EVALUATION OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAM
NATIONWIDE EVALUATION OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAM

Esther Toes-Zoutendijk  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Esther Toes-Zoutendijk  et al.

RISK PREDICTION FOR ADVANCED NEOPLASIA USING LONGITUDINAL ADHERENCE MEASURES TO FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAMS
RISK PREDICTION FOR ADVANCED NEOPLASIA USING LONGITUDINAL ADHERENCE MEASURES TO FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAMS

Esther Toes-Zoutendijk  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Esther Toes-Zoutendijk  et al.

Item 1 - 14 / 14
1